StockData
Lisata Therapeutics, Inc. logo

Lisata Therapeutics, Inc. (LSTA) stock

LSTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.04−0.05 (-4.59%)

Close on Nov 17, 2026Market cap $9.37MP/E –Yield –

Lisata Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Lisata Therapeutics's price to book ratio was 1.3× on Nov 11, 2026, against 1.0× a year earlier. Over the last 5 years it ranged from 0.2× to 3.0×, with a median of 0.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.3×+0.4
2025Dec 31, 20250.9×+0.2
2024Dec 31, 20240.7×+0.3
2023Dec 29, 20230.4×+0.1
2022Dec 30, 20220.3×−0.2
2021Dec 31, 20210.5×−0.2
2020Dec 31, 20200.7×−0.3
2019Dec 31, 20191.0×+0.2
2018Dec 31, 20180.9×+0.2
2017Dec 29, 20170.6×−1.5
2016Dec 30, 20162.2×+1.1
2015Dec 31, 20151.1×−1.0
2014Dec 31, 20142.1×−1.9
2013Dec 31, 20134.0×+2.1
2012Dec 31, 20121.9×+1.2
2011Dec 30, 20110.7×–

More Lisata Therapeutics figures

See a number that looks wrong?